ScreenerHero
VIMIANVimian Group AB
STO · SE · Healthcare · Diagnostics & Research · vimian.com
34.85SEK-0.85%Mkt Cap: 1.78B $P/E: 45.65

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, pres…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.64BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMerieux S.A.
$9.51BUSDP/E 19.0
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap1.78B $
Enterprise Value24.52M $
Revenue (TTM)43.13M $
Gross Profit28.01M $
Net Income (TTM)2.99M $
Revenue/Share0.0816 USD
Last Price34.85 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.3K
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISINSE0015961982
Valuation
P/E (Trailing)45.65
P/E (Forward)26.35
PEG—
EV/EBITDA2.25
EV/Revenue0.57
P/S41.05
P/B25.68
EPS (TTM)0.77
EPS (Forward)1.33
52W Range
24.1891% of range35.90
52W High35.90 SEK
52W Low24.18 SEK
Profitability
Gross Margin68.89%
Oper. Margin18.42%
EBITDA Margin25.33%
Profit Margin7.36%
ROE4.48%
ROA2.82%
Growth
Revenue Growth16.60%
Earnings Growth0.20%
Cash Flow & Leverage
Operating CF10.11M $
CapEx (TTM)1.44M $
FCF Margin8.37%
FCF Yield0.20%
Net Debt21.73M $
Net Debt/EBITDA1.99
Balance Sheet
Debt/Equity0.34
Current Ratio2.43
Quick Ratio1.35
Book Value/Sh1.365 SEK
Cash/Share97.29 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)36.63 SEK
Upside (mean)+5.1%
Target Range28.92 SEK – 42.18 SEK
SEK28.92+5.1% to meanSEK42.18
# Analysts6
Ownership
Shares Out.527.06M
Float187.35K
Insiders6.45%
Institutions86.06%
Technical
SMA 5032.36 (+7.7%)
SMA 20029.61 (+17.7%)
Beta1.19
S&P 52W Chg18.16%
Avg Vol (30d)211.15K
Avg Vol (10d)205.77K
Technical Indicators
RSI (14)60.9
MACD0.8090
MACD Signal0.9469
MACD Hist.-0.1379
BB Upper35.86 SEK
BB Middle34.73 SEK
BB Lower33.61 SEK
BB Width6.50%
ATR (14)0.9076 SEK
Vol Ratio (20d)0.54x